The mistake European buyers make first
The thesis that justifies buying in Europe today is a distress discount: compressed multiples, constrained sellers, a credit cycle doing the work. Applied to India, that thesis is simply wrong, and it is worth being explicit about why.
The Indian financial system is healthy. The policy rate is stable, credit is growing, non-performing loans are at a low, and GDP is advancing at close to 7%. There is no distress discount to capture. A European acquirer who arrives expecting one will be met with valuations that reflect growth, not difficulty, and will conclude the market is expensive.
They will have missed the actual arbitrage, which is not about the seller being cornered. It is about what the seller cannot afford to do.
A cost of capital, not a distress discount
The Indian mid-market borrows at between 12% and 24%, while large domestic conglomerates finance themselves at the reference rate. That asymmetry is the defining financial fact of the segment. The owner of a €40M-revenue speciality chemicals business in Gujarat is not under pressure to sell; they are under pressure on their cost of capital, which constrains every investment decision they take.
For an acquirer able to refinance in euros, the consequence is immediate: replacing debt priced at 16% with debt priced at 6% creates value in the first year, with no operational improvement whatsoever. That is a different arbitrage from the European one, and an equally powerful one.
The wall itself
Onto that financing asymmetry lands an obligation. The European carbon border adjustment mechanism, together with the general tightening of European import standards, requires any Indian producer selling into Europe to invest in measurement, decarbonisation and traceability, emissions accounting at product level, verified data, process changes, and the systems to sustain all of it.
This is not a compliance cost that can be deferred. It is the condition of keeping European market access. And it arrives precisely at the moment when the mid-market's cost of capital makes funding it hardest.
One scope caveat matters, and we state it in every mandate. The mechanism currently covers six product categories, including steel, aluminium and fertilisers, but neither fine chemicals nor finished components. A European buyer told that the mechanism directly binds a speciality chemicals target is being sold a story. What binds that target is the direction of European standards and the requirements its European customers are already passing down the chain, which is real but is not the same thing.
A currency and input squeeze on top
A cyclical factor sharpens the picture. The 2026 United States–Iran crisis pushed crude above $114 a barrel and cost the rupee close to 10% over the year. Imported inputs and imported equipment became more expensive at the exact moment Indian industry needed to invest in both.
For an acquirer holding euros, that is a strengthening of purchasing power. For the Indian owner, it is one more reason the investment cannot be self-funded.
Why a European acquirer is the only counterparty
A domestic financial investor can supply capital. A domestic conglomerate can supply capital and scale. Neither can supply the engineering.
A European industrial acquirer is the only counterparty able to bring, at the same time, the decarbonisation engineering, the measurement systems and the capital, and, decisively, the European market access that makes the whole investment worth making. That is a proposition no local buyer can match, and it is the strongest hand a European buyer holds in India.
What this changes in how you approach a seller
The practical conclusion is a communication one, and it inverts the European playbook. In Europe, the argument that persuades a seller is access to a solvent buyer. In India, the argument is technology, certification and market access, never price.
An approach built on valuation will read as opportunistic and will usually end the conversation. An approach built on what the acquirer brings to a business that intends to keep growing is a different discussion entirely, and it is the one worth having.
Key takeaways
- There is no distress discount in India: stable rates, growing credit, low NPLs, GDP near 7%.
- The real arbitrage is cost of capital, the mid-market borrows at 12–24% against the reference rate for conglomerates.
- European carbon border and import-standard requirements impose an investment the mid-market cannot self-fund.
- Scope caveat: the mechanism covers six product categories, not fine chemicals or finished components.
- A European acquirer alone brings engineering, measurement systems, capital and market access together.
- In India the persuasive argument is technology and market access, never price.
Weighing an acquisition on the corridor?
Open a confidential conversation. We reply on average within two business days, and the first phase of a mandate is sold on its own, a dated, verifiable deliverable with no obligation to continue.
Contact us